Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ruthenium catalyzed. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105801578B details a one-step catalytic route for semi-saturated pyrazines, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN109665958B details a green ruthenium-catalyzed route to polysubstituted 1-naphthoic acids using air oxidation, offering significant cost and supply chain advantages for pharmaceutical intermediates.
Novel ruthenium-catalyzed route offers mild conditions and significant cost reduction in API manufacturing for high-purity pharmaceutical intermediates supply chain optimization.
Patent CN1033700C reveals a hydrogen-free ruthenium-catalyzed method for producing linear acrylonitrile dimers with high selectivity, offering significant safety and cost advantages for nylon 66 precursor manufacturing.
Advanced patent CN1086187C analysis for Dicyclohexyl-18-crown-6. Offers safer synthesis, cost reduction in specialty chemical manufacturing, and high-purity supply chain solutions.
Patent CN106977481A reveals a novel Ru-Sn-Cu catalytic system for coumarin derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Efficient Ru-catalyzed synthesis of N-sulfenyl-N-allyl amides. Mild conditions, high yield, scalable for pharma intermediates. Cost-effective supply chain solution.
Patent CN115925527A details a Ru-catalyzed hydroarylation for alpha-diarylmethyl ketones, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Novel ruthenium-catalyzed method for condensed ring amides. High yield, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Novel Ruthenium-catalyzed method for condensed ring amides. High yield, scalable process reducing costs for pharmaceutical manufacturing and supply chain reliability.
Novel Ru-catalyzed one-pot synthesis of furan acrylates from biomass. High yield, scalable, cost-effective for pharma intermediates.
Novel ruthenium-catalyzed route for high-purity carborane intermediates enabling cost-effective BNCT drug development and scalable supply chain solutions.
Novel ruthenium catalysis for methyl ester selective dehydroboration. Offers significant cost reduction and supply chain reliability for high purity pharmaceutical intermediates manufacturing.
Novel ruthenium catalyst recovery method for adamantane polyol manufacturing ensuring cost efficiency and supply chain stability for global buyers.
Patent CN112939892A reveals a green Ru-catalyzed route for quetiapine intermediates. Achieve high purity and yield with water as the only byproduct for cost-effective API manufacturing.
Patent CN112300061B details a novel Ru-catalyzed C-H acylation method using amides, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates.
Patent CN102040584A reveals a high-selectivity hydrogenation route for DCH18C6, offering significant cost reduction in specialty chemical manufacturing through simplified purification.
Efficient Ru-catalyzed C-H activation for 5-maleimide chromones. High yield, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN102942542A details a cost-effective Ru-catalyzed route for 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid, offering significant supply chain advantages.
Patent CN106349102B reveals a safe ruthenium-catalyzed route for meta-alkyl azo aromatic compounds, offering significant cost reduction and supply chain reliability for global buyers.